Incremental Hemodialysis: The University of California Irvine Experience

Seminars in Dialysis

Volumn 30, Issue 3, 2017, Pages 262-269

  Ghahremani Ghajar, Mehrdad ^a   Rojas Bautista, Vanessa ^a   Lau, Wei Ling ^a   Pahl, Madeleine ^a   Hernandez, Miguel ^a   Jin, Anna ^b   Reddy, Uttam ^a   Chou, Jason ^a   Obi, Yoshitsugu ^a   Kalantar Zadeh, Kamyar ^a,b   Rhee, Connie M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CALIFORNIA; CHRONIC KIDNEY FAILURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME FACTOR; TREATMENT OUTCOME; TRENDS; UNIVERSITY HOSPITAL; YOUNG ADULT;

ADULT; AGED; CALIFORNIA; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HOSPITALS, UNIVERSITY; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85015292657     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12591     Document Type: Article

References (35)

1. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12(10):2158–2162, 2001
2. Canaud B: Residual renal function: the delicate balance between benefits and risks. Nephrol Dial Transplant 23(6):1801–1805, 2008
3. Chandna SM, Farrington K: Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial 17(3):196–201, 2004
4. Morduchowicz G, Winkler J, Zabludowki JR, Boner G: Effects of residual renal function in haemodialysis patients. Int Urol Nephrol 26(1):125–131, 1994
5. Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, et al.: Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol 27(12):3758–3768, 2016
6. Paniagua R, Amata D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al.: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13(5):1307–1320, 2002
7. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, et al.: Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56(2):348–358, 2010
8. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT, et al.: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15(4):1061–1070, 2004
9. van der Wal WM, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, et al.: Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26(9):2978–2983, 2011
10. Vilar E, Farrington K: Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24(5):487–494, 2011
11. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K, et al.: Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24(8):2502–2510, 2009
12. US Renal Data System, USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2011:10.
13. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, et al.: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2(1):89–99, 2007
14. Lukowksky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K: Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol 35(6):548–558, 2012
15. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, et al.: Effect of frequent hemodialysis on residual kidney function. Kidney Int 83(5):949–958, 2013
16. Diao Z, Zhang D, Dai W, Ding J, Zhang A, Liu W: Preservation of residual renal function with limited water removal in hemodialysis patients. Ren Fail 33(9):875–877, 2011
17. Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, et al.: Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology 14(1):59–64, 2009
18. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT, et al.: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62(3):1046–1053, 2002
19. Lysaght MJ, Vonesh E, Gotch F, Ibels L, Keen M, Lindholm B, et al.: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37(4):598–604, 1991
20. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4(5):914–920, 2009
21. Hyodo T, Koutoku N: Preservation of residual renal function with HDF. Contrib Nephrol 168:204–212, 2011
22. Bricker NS, Morrin PA, Kime SW Jr: The pathologic physiology of chronic Bright's disease. An exposition of the “intact nephron hypothesis”. Am J Med 28:77–98, 1960
23. Agrawal A, Saran R, Nolph KD: Continuum and integration of pre-dialysis care and dialysis modalities. Perit Dial Int 19(Suppl 2):S276–S280, 1999
24. Daugirdas JT, Kjellstrand C: Chronic hemodialysis prescription: a urea kinetic approach. Handbook Dial 4:146–170, 1994
25. Kalantar-Zadeh K, Unruh M, Zager PG, Kovesdy CP, Bargman JM, Chen J, et al.: Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64(2):181–186, 2014
26. Keshaviah PR, Emerson PF, Nolph KD: Timely initiation of dialysis: a urea kinetic approach. Am J Kidney Dis 33(2):344–348, 1999
27. Mehrotra R, Nolph KD, Gotch F: Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int 17(5):426–430, 1997
28. Rosansky SJ, Cancarini G, Clark WF, Eggers P, Germaine M, Glassock R, et al.: Dialysis initiation: what's the rush? Semin Dial 26(6):650–657, 2013
29. Lin X, Yan Y, Ni Z, Gu L, Zhu M, Dai H, et al.: Clinical outcome of twice-weekly hemodialysis patients in shanghai. Blood Purif 33(1–3):66–72, 2012
30. Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, et al.: Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68(2):256–265, 2016
31. Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, et al.: Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 19(6):625–633, 1999
32. Hemodialysis Adequacy Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48(Suppl 1):S2–S90, 2006
33. NKF-DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 30(3):S17–S63, 1997
34. Jones C, Roderick P, Harris S, Rogerson M: Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 21(8):2133–2143, 2006
35. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al.: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11(3):556–564, 2000